Transcat Chief Financial Officer, John J. Zimmer, to Retire

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Transcat Chief Financial Officer, John J. Zimmer, to Retire in 2016

ROCHESTER, N.Y., Dec. 10, 2015 (GLOBE NEWSWIRE) -- Transcat, Inc. (NASDAQ: TRNS ) ("Transcat" or the "Company"), a leading provider of accredited calibration and compliance services and distributor of professional grade handheld test, measurement and control instrumentation, announced today that following a distinguished, 30-year career in finance and accounting, John J. Zimmer, Senior Vice President of Finance and Chief Financial Officer, will retire from Transcat in 2016. The Company also announced that MichaeI J. Tschiderer has joined Transcat, effective today, as Vice President of Finance and will succeed Mr. Zimmer as Chief Financial Officer on March 27, 2016.

Commenting on his decision to retire, Mr. Zimmer stated, "It has been a privilege serving as Transcat's CFO during the past nine years. As a team, we have built a strong business with excellent people that deliver high-quality products and services to our continually expanding customer base. We achieved scale through acquisition and organic growth in our calibration services business and significantly grew our distribution business. With great confidence in the Company's future, I look forward to watching Transcat succeed as I turn to a new chapter in life. I envision a seamless transition with Mike, after which I will turn my focus toward my family and pursue other life goals."

Lee D. Rudow, President and CEO, commented, "John has made many contributions to Transcat and I personally have appreciated his wise counsel. We greatly appreciate John's outstanding service throughout his tenure, as well as his flexibility in planning his retirement to provide adequate time to transition his responsibilities to Mike. We wish John all the best as he changes course in life." 

Mr. Rudow added, "We are also fortunate to have a financial executive of Mike's caliber and experience join us. We are confident his financial and business expertise and leadership capabilities will make for a smooth transition as he steps into the role of chief financial officer." 

Over the course of his career, Mr. Tschiderer has served in several senior financial executive positions, including CFO, in technology, telecommunications, manufacturing and environmental energy companies, as well as having Big 4 public accounting experience. He most recently served as Global Controller with LanzaTech, Inc., a global leader in gas fermentation technology that uses waste carbon streams to develop fuels and high-value chemicals. His experience covers the full spectrum of public company financial functions, including financial management, treasury, SEC financial reporting and investor relations. Mr. Tschiderer is a certified public accountant (inactive) and holds a Bachelor of Business Administration from St. Bonaventure University.  

ABOUT TRANSCAT

Transcat, Inc. is a leading provider of accredited calibration and compliance services, including analytical instrument qualifications, equipment and process validation. The Company is focused on providing best-in-class calibration analytics to highly regulated industries, including life science, aerospace, pharmaceuticals, medical device manufacturing and biotechnology. Transcat performs over 250,000 specialized technical services annually through a variety of delivery options, including permanent and periodic on-site services, mobile calibration services and in-house services (often accompanied by pick-up and delivery). The in-house services are offered through 19 Calibration Service Centers strategically located across the United States, Puerto Rico and Canada. The breadth and depth of measurement parameters addressed by Transcat's ISO/IEC 17025 scopes of accreditation are believed to be the best in the industry. Transcat also answers the call with cGMP and GLP compliant services.

In addition, Transcat operates as a leading distributor of professional grade handheld test, measurement and control instrumentation, marketing more than 100,000 premier and proprietary brand instruments to approximately 22,000 customers.  

Transcat's growth strategy is to leverage its service capabilities, strong brand and leading distribution platform to drive organic sales growth and to expand its addressable calibration market through acquisitions and capability investments to further realize the inherent leverage of its business model.

More information about Transcat can be found on its website at: Transcat.com .

For more information contact: John J. Zimmer, Chief Financial Officer Phone: (585) 352-7777 Email: -or- Deborah K. Pawlowski, Investor Relations Phone: (716) 843-3908 Email:

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Russel Metals Shows Strong Performance in Latest Earnings Report

Updated Category News Views 240

Russel Metals Inc. Reports Third Quarter Results for 2025 Russel Metals Inc. (TSX:RUS) has recently shared its financial performance for the three-month period ending September 30, 2025. The results reflect a positive trajectory in revenue and strategic initiatives to enhance its market position. Key Financial Metrics Overview In this quarter, Russel Metals has...

Continue Reading
KBC Group Shows Strong Capital Resilience Ahead of Changes

Updated Category News Views 257

KBC Group's Capital Position Remains Strong KBC Group has reported a robust standing in its capital levels, significantly exceeding the minimum capital requirements mandated by the European Central Bank (ECB). As part of the Supervisory Review and Evaluation Process (SREP) scheduled for the upcoming year, KBC received formal notification regarding its capital metrics....

Continue Reading
Synlogic's Q3 Financial Update Highlights Strategic Review

Updated Category News Views 79

Synlogic Provides Third Quarter 2024 Financial Results Synlogic, Inc. (NASDAQ: SYBX), a prominent biopharmaceutical firm dedicated to developing innovative therapeutics for serious diseases, has recently outlined its financial performance for the third quarter of 2024. The organization is actively working on advancing its mission to enhance healthcare through...

Continue Reading
Incannex Healthcare Sees Growth with Positive Fiscal Results

Updated Category News Views 98

Incannex Healthcare's Remarkable Financial Progress Incannex Healthcare Inc. (NASDAQ: IXHL) is making impressive strides in the biopharmaceutical world, focusing on breakthrough treatments for chronic diseases. Their recent fiscal year report outlines not only financial outcomes but also a plethora of operational and clinical advancements aimed at addressing significant...

Continue Reading
Revolutionizing Finance with ChatAnalyst at Alpha Liquid Terminal

Updated Category News Views 167

Alpha Liquid Terminal Introduces ChatAnalyst Financial Agent Recently, a game-changing tool was launched that promises to redefine how individuals manage and interpret financial data. This is powered by the innovative company, Alpha Liquid Terminal. The newly unveiled AI-driven financial analyst agent, known as ChatAnalyst, is designed to simplify and streamline financial...

Continue Reading